Generate a tailored SOP for Dr. Simonetta Federico. Improve your application with a focused, well-structured draft.
Simonetta Federico is a prominent researcher in the field of oncology and hematology, currently serving as the Chief Scientific Clinic at the Translational Research Centre for Oncohaematology at the University of Geneva. With a medical degree from the University of Genoa and advanced degrees in Immunology from the Pasteur Institute and the University of Paris-Sud, her career has been dedicated to the intersection of clinical practice and research in hematological malignancies. Dr. Federico's work emphasizes the development of CAR T-cell therapies and the study of graft-versus-host disease (GvHD). Throughout her career, she has been involved in various collaborations on cellular therapies, contributing to significant advancements in immune-effector and immune-regulatory therapeutic approaches. She is recognized for her expertise in multiparametric immunomonitoring techniques. Dr. Federico has held postdoctoral positions, including one at Stanford University, and has actively contributed to study groups within European and international healthcare organizations. Her extensive research interests revolve around the mechanisms of immune reconstitution following allogeneic hematopoietic stem cell transplantation and the identification of biomarkers for immune monitoring. She has co-authored numerous influential publications in leading academic journals, underscoring her contributions to the field of hematology and transplant medicine.
Translational Research Centre on Oncohaematology, University of Geneva • Geneva, Switzerland
Split between clinical work and research in hematology.
Stanford University • Stanford, USA
Focused on research related to CAR T cell therapies and immune responses.
Includes Department of Management, Finance, Economics, and Statistics programs. GMAT is strongly encouraged but not mandatory for most GSEM masters.